Professional Documents
Culture Documents
MMC 2
MMC 2
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
50
b-actin
37
HT29
HT29
kDa
kDa
VC RSL3
150 PERK
100
50 b-actin
37
SW620 SW620
kDa kDa SW620
kDa
VC RSL3 VC RSL3
VC RSL3
150 IRE1a
100 100
75 ATF6-P
ATF6-N 50
50 b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
DLD1 DLD1
kDa
VC RSL3
kDa VC RSL3
150 PERK
100
50
b-actin
37
DLD1 DLD1
kDa DLD1
kDa
VC RSL3 kDa
VC RSL3 VC RSL3
150 IRE1a
100 100 ATF6-FL
75 ATF6-P
ATF6-N 50
50 b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HCT116 HCT116
kDa
VC RSL3
kDa
50
b-actin
37
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29
VC RSL3
kDa HT29
15 kDa GPx4 VC RSL3
50
37 SLC7A11
25
HT29
kDa
kDa HT29 VC RSL3
50
VC RSL3 37 b-actin
75 ACSL4
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29 HT29
kDa
kDa 50
EV PERK KD EV PERK KD
37
150 PERK
SLC7A11
100
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29
HT29 kDa
HT29 kDa EV ATF6 KD
EV ATF6 KD
kDa
50
EV ATF6 KD 37 SLC7A11
20
25 GPx4
150
100 ATF6
HT29
kDa
EV ATF6 KD
HT29
50 b-actin
37
kDa EV ATF6 KD
150
100 ACSL4
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29 HT29
kDa
kDa
EV IRE1a KD
IRE1a 150 EV IRE1a KD
100 100
75
ACSL4
HT29 kDa
HT29 HT29
kDa kDa
EV IRE1a KD
EV IRE1a KD
50 50
b-actin
SLC7A11 37
37
EV IRE1a KD
25
GPx4 20
15
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29 RSL3
PERK PERK
EV EV
kDa KD KD
HT29
kDa
RSL3 50
SLC7A11
EV
PERK
EV
PERK 37
KD KD
150 PERK 25
100
HT29
RSL3
kDa EV
PERK
EV
PERK
KD KD
50 b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29 HT29
kDa PERK
VC inhibitor
kDa PERK b-actin
VC inhibitor HT29 50
50 SLC7A11 kDa
PERK 37
37
VC inhibitor
150 PERK
100
25
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29
HT29
kDa
kDa
VC RSL3 RSL3+ 50
VC RSL3 RSL3+ inhibitor
inhibitor 37
SLC7A11
PERK 150
100
HT29
kDa
VC RSL3 RSL3+
inhibitor
50
b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29
kDa Cystine-
Cystine+
HT29
kDa 50 EV PERK KD EV PERK KD
150 PERK
100
HT29
kDa
50
b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
SW620
kDa Cystine+ Cystine- SW620
EV PERK KD EV PERK KD kDa
Cystine+ Cystine-
PERK
150 50 EV PERK KD EV PERK KD
100 SLC7A11
37
SW620
Cystine+ Cystine-
kDa EV PERK KD EV PERK KD
50
b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29
kDa Cystine-
Cystine+
HT29 PERK PERK
kDa 50 VC Inhibitor EV Inhibitor
150 PERK
100
HT29
Cystine+ Cystine-
PERK PERK
kDa VC Inhibitor EV Inhibitor
50 b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
SW620
kDa Cystine+ Cystine- SW620
PERK PERK
VC Inhibitor EV Inhibitor kDa Cystine+ Cystine-
PERK PERK
150 PERK 50 VC Inhibitor EV Inhibitor
100
37 SLC7A11
SW620
Cystine+ Cystine-
kDa PERK PERK
VC Inhibitor EV Inhibitor
50
b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
25-
20-
HT29 HT29
EV PERK KD
250-
150-
100-
75- EV PERK KD
50- 50 b-actin
37- MDA 37
25-
20-
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
VC PERK
Inhibitor
250- VC PERK
150- Inhibitor
100- 50 b-actin
75-
37
50-
37- 4-HNE
25-
20-
HT29
HT29
-250
VC PERK -150
Inhibitor -100 VC PERK
Inhibitor
-75
-50 b-actin 50
-37 37
MDA -25
-20
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
Un-cropped Immuno-blot Images -Figure- 3C
HT29
HT29 kDa RSL3
kDa VC FER-1 VC FER-1
RSL3 HT29
VC FER-1 VC FER-1 RSL3
VC FER-1 VC FER-1
150 kDa
PERK
100 75 50
GRP78 b-actin
50
37
HT29
HT29 RSL3
kDa
RSL3 VC FER-1 VC FER-1
VC FER-1 VC FER-1
kDa
50
ATF4
50 b-actin
37
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
kDa kDa
HT29 HT29
Thapsigargin - + + -
kDa HT29 PERK inhibitor - - + + Thapsigargin - + + -
50 ATF4 PERK inhibitor - - + +
Thapsigargin - + + - 50
PERK inhibitor - - + + 37 SLC7A11
37
150 PERK
25
100
kDa HT29
Thapsigargin - + + -
PERK inhibitor - - + +
50
b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
HT29
kDa
EV PERK
KD kDa HT29
PERK EV PERK
150
100 KD
50 ATF4
37
kDa HT29
HT29
kDa
EV PERK
KD
EV PERK 50
KD b-actin
50 37
SLC7A11
37
25
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
25
kDa
HT29
EV ATF4
HT29 50 KD
kDa
EV ATF4 37 b-actin
KD
150 PERK
100
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
EV PERK KD
SLC7A11 SLC7A11
kDa Control OE Control OE
50
37 SLC7A11
150 PERK
100
50
b-actin
37
HT29
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
Un-cropped Immuno-blot Images -Figure- 4D
EV KD EV KD EV KD EV KD
50 EV KD EV KD EV KD EV KD 50
SLC7A11 37
37
25
EV KD EV KD EV KD EV KD
50
EV KD EV KD EV KD EV KD
37 b-actin
50
37
Continue…
kDa kDa
EV KD EV KD EV KD EV KD EV KD EV KD EV KD EV KD
37 37 GAPDH
25 4-HNE 25
20
15
EV KD EV KD EV KD EV KD
150
100
75
HT29 Mice tumors
50
MDA
37 EV KD EV KD EV KD EV KD
25 37 GAPDH
20
15 25
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
SW620
HT29 HT29 HT29 SW620
VC RSL3
VC RSL3 VC RSL3 VC RSL3 VC RSL3 kDa
kDa kDa
kDa
100
75 GRP78
b-actin
50 ATF4 50
50
b-actin b-actin
37 37 37
Continue…
HCT116 HCT116 HCT116
HCT116
kDa kDa
VC RSL3 kDa VC RSL3 VC RSL3
kDa VC RSL3
100
75 GRP78
50 ATF4 50 b-actin
37 50 b-actin 37
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
SW620 DLD1
kDa VC RSL3 HCT116
kDa VC RSL3 VC RSL3
GPx4 kDa
15
15 GPx4
15 GPx4
50 50
37 SLC7A11 37
50 SLC7A11
37 SLC7A11
25
75 ACSL4 75
ACSL4
75 ACSL4
50 50
b-actin
50 37 37 b-actin
37 b-actin
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
Un-cropped Immuno-blot Images - Supplementary Figure- 3
SW620
RSL3
PERK PERK
EV EV
KD KD
kDa
PERK
150
100
kDa
50
37 SLC7A11
kDa
50
b-actin
37
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
kDa
50 b-actin
50 b-actin 37
37 37 GAPDH
Loss of PERK function promotes ferroptosis by downregulating System Xc⁻(SLC7A11) in colorectal cancer Saini et al.
Division of Cancer Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India
75-
100- 100- 100- 100-
75- 75- 75- 75-
75-
50-
50- 4-HNE 50- 50- 50-
4-HNE 50- MDA
MDA 37- 37- 37- 4-HNE 37-
MDA
37- 37-
25- 25- 25- 25-
25- 20- 20- 20- 20-
25-
20-
20-
50
b-actin
50 37 50 b-actin
50 b-actin
b-actin 37 50 50
37
37 b-actin b-actin
37 37